CN117479929A - 控制活性物质向消化道施用的方法 - Google Patents

控制活性物质向消化道施用的方法 Download PDF

Info

Publication number
CN117479929A
CN117479929A CN202280041826.5A CN202280041826A CN117479929A CN 117479929 A CN117479929 A CN 117479929A CN 202280041826 A CN202280041826 A CN 202280041826A CN 117479929 A CN117479929 A CN 117479929A
Authority
CN
China
Prior art keywords
capsule
hpmc
sample
capsules
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280041826.5A
Other languages
English (en)
Chinese (zh)
Inventor
A·贝拉明
T·怀特
S·德基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza Greenwood LLC
Original Assignee
Lonza Greenwood LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Greenwood LLC filed Critical Lonza Greenwood LLC
Publication of CN117479929A publication Critical patent/CN117479929A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202280041826.5A 2021-06-24 2022-06-23 控制活性物质向消化道施用的方法 Pending CN117479929A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163214438P 2021-06-24 2021-06-24
US63/214,438 2021-06-24
PCT/US2022/034683 WO2022271922A1 (en) 2021-06-24 2022-06-23 Method to control administration of active substance to the digestive tract

Publications (1)

Publication Number Publication Date
CN117479929A true CN117479929A (zh) 2024-01-30

Family

ID=84544830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280041826.5A Pending CN117479929A (zh) 2021-06-24 2022-06-23 控制活性物质向消化道施用的方法

Country Status (8)

Country Link
US (1) US20240285699A1 (cg-RX-API-DMAC7.html)
EP (1) EP4340819A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024526149A (cg-RX-API-DMAC7.html)
CN (1) CN117479929A (cg-RX-API-DMAC7.html)
AU (1) AU2022299196A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023027371A2 (cg-RX-API-DMAC7.html)
CA (1) CA3223905A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022271922A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116270523B (zh) * 2023-05-15 2023-08-08 四川厌氧生物科技有限责任公司 一种耐酸的口服双层胶囊及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2667167C (en) * 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
BR112012006651B1 (pt) * 2009-09-24 2021-11-03 Capsugel Belgium Nv Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
US9907755B2 (en) * 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP3028694B1 (en) * 2014-12-02 2017-07-12 Capsugel Belgium NV Dosage form articles for delayed release
EP3882259B1 (en) * 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US20190388344A1 (en) * 2018-06-22 2019-12-26 Probiotech Llc Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
US20200038215A1 (en) * 2018-08-01 2020-02-06 Ethicon, Inc. Transient implantable device to control absorption of nutrients
US12144834B2 (en) * 2018-09-13 2024-11-19 Xbiome Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
CA3117956A1 (en) * 2018-10-30 2020-05-07 Vitabolus Inc. Oral delivery of therapeutic mammalian cells
MX2022004515A (es) * 2019-10-16 2022-07-12 Capsugel Belgium Nv Metodo y composicion para aumentar la sintesis de proteinas musculares.

Also Published As

Publication number Publication date
AU2022299196A1 (en) 2023-12-21
CA3223905A1 (en) 2022-12-29
BR112023027371A2 (pt) 2024-03-12
JP2024526149A (ja) 2024-07-17
EP4340819A4 (en) 2025-04-02
WO2022271922A1 (en) 2022-12-29
EP4340819A1 (en) 2024-03-27
US20240285699A1 (en) 2024-08-29

Similar Documents

Publication Publication Date Title
JP6860596B2 (ja) プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
US7122370B2 (en) Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
JP4444496B2 (ja) 低温コーティング
JP3752421B2 (ja) 乳酸菌の安定化のための微細腸溶性コーティング顆粒
US9962335B2 (en) Method of manufacturing enteric soft capsule
TWI584824B (zh) A capsule for delivery to a large intestine and a method of manufacturing the same
JP2019504886A (ja) 経口コレスチラミン製剤及びその使用
Marzorati et al. Comparison of protection and release behavior of different capsule polymer combinations based on L. acidophilus survivability and function and caffeine release
CN102883712A (zh) 耐胃液酶药物组合物
US20240285699A1 (en) Method to Control Administration of Active Substance to the Digestive Tract
CN1475208A (zh) 舍曲林的缓释剂型
JP5907796B2 (ja) 腸内環境改善食品
US20240374526A1 (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
JP2004250338A (ja) 有用生菌製剤
RU2783157C2 (ru) Гранулы холестирамина, пероральные композиции холестирамина и их применение
RU2782016C2 (ru) Пеллеты холестирамина, пероральные композиции холестирамина и их применение
RU2782016C9 (ru) Пеллеты холестирамина, пероральные композиции холестирамина и их применение
CN117257845A (zh) 靶向投递活益生菌的方法
JP2023020095A (ja) 腸溶性固形製剤
HK40012186A (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
NZ711298B2 (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination